Women in Pharmaceutical and Biotechnology Industry
Given the current global challenges, there is a growing demand to create a new mindset concerning healthcare. Improving the availability and efficiency of drug supply is one of the key tasks of the national healthcare industry. Women are actively involved in the scientific development of modern medicines and ensure the smooth operation of enterprises that produce modern medicines. What are the priority focuses for the development of pharmaceuticals in the current conditions? How can the manufacturing of domestic drugs be expanded to meet the demand for high-quality and affordable drugs in Russia? What resources do companies need to develop the production of affordable drugs? What improvements can be made to the training and retraining of staff at modern pharmaceutical enterprises? What new health protection technologies are most effective in preventing serious diseases and building a healthy society?
Tatyana Yakovleva, First Deputy Head, Federal Medical-Biological Agency of the Russian Federation
Elena Baranova, Founder, Baranova Monaco; President, EU Institute of Personalized Prevention and Health
Oksana Drapkina, Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Galina Karelova, Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation
Elena Maksimkina, Director, "Federal Center for Planning and Regulation Of Medical Supply Circulation" of the Ministry of Health of the Russian Federation
Tatyana Semenova, Deputy Minister of Health of the Russian Federation
Anastasia Stolkova, Director of "Women for a Healthy Society"
Lyudmila Scherbakova, Co-Founder, Chairman of the Board of Directors, Velpharm LLC
Front row participant
Lyalya Gabbasova, Deputy Director for General Affairs, Medical Research and Education Center, Lomonosov Moscow State University